Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (9)

2023

  1. Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics

    Antioxidants, Vol. 12, Núm. 2

2019

  1. Investigation on the Existence of Sex-By-Formulation Interaction in Bioequivalence Trials

    Clinical Pharmacology and Therapeutics, Vol. 106, Núm. 5, pp. 1099-1112

  2. Sex-by-formulation interaction in bioequivalence trials with transdermal patches

    European Journal of Clinical Pharmacology, Vol. 75, Núm. 6, pp. 801-808

2018

  1. Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets

    British Journal of Clinical Pharmacology, Vol. 84, Núm. 8, pp. 1729-1737

2015

  1. Critical attributes of formulation and of elaboration process of PLGA-protein microparticles

    International Journal of Pharmaceutics, Vol. 480, Núm. 1-2, pp. 27-36

  2. Overcoming glucocorticoid resistances and improving antitumor therapies: Lipid and polymers carriers

    Pharmaceutical Research, Vol. 32, Núm. 3, pp. 968-985

2012

  1. The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/- Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treat-ments

    Current Drug Metabolism, Vol. 13, Núm. 9, pp. 1303-1312

2008

  1. Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers

    Pharmacological Research, Vol. 58, Núm. 1, pp. 77-84

2005

  1. An eutomer/distomer ratio near unity does not justify non-enantiospecific assay methods in bioequivalence studies

    Chirality, Vol. 17, Núm. 8, pp. 470-475